org placeholder image

Cyril Empig

Lead, Non-Clinical Studies at Uvax Bio

  • LinkedIn

Email Email: c****@uvaxbio.com

phone noPhone Number: (***)-***-****

map
UVAX BIO

UVAX BIO

  • Headquarter Headquarters: 660 W Germantown Pike, Newark, Delaware, 19462, United States
  • Industry Industry Biotechnology
  • website Website uvaxbio.com
  • description Description
    Founded in early 2018, Uvax Bio, a spin-off vaccine company from Scripps Research, La Jolla, CA, employs patented single-component self-assembling protein nanoparticle (1c-SApNP) platform tec...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 250 Million to 500 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Uvax Bio Org Chart and Mapping

Employees

Matthijs Schoots

Chief of Staff, Head Strategic Planning

Cyril Empig

Lead, Non-Clinical Studies

Benjamin Wang

Business Development Associate

Ke Li

Vice President, Vaccine Development and Technical Ops

Kevin O'Neill

Senior Vice President, Corporate Strategy

Frequently Asked Questions Regarding Cyril Empig

Answer: Cyril Empig works for Uvax Bio as Lead, Non-Clinical Studies

Answer: Cyril Empig’s role in Uvax Bio is Lead, Non-Clinical Studies

Answer: Cyril Empig's email address is c***@gmail.com

Answer: Cyril Empig's business email address is c****@uvaxbio.com

Answer: Cyril Empig’s direct phone number is (***)-***-****

Answer: Cyril Empig works in the industry of: Biotechnology

Answer: Cyril Empig works Uvax Bio located at 660 W Germantown Pike, Newark, Delaware, 19462, United States

Answer: Uvax Bio's Lead, Non-Clinical Studies is Cyril Empig

Answer: Cyril Empig contact details:

  • Phone number  :  (***)-***-****
  • Email  :  c****@uvaxbio.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access